Impact of very early introduction of everolimus on liver regeneration after partial liver transplantation in rats

Impact of very early introduction of everolimus on liver regeneration after partial liver transplantation in rats
复制标题

早期使用依维莫司对大鼠部分肝移植后肝再生的影响

DOI:
10.1002/jhbp.1310
复制
发表时间:
2023
影响因子:
3
通讯作者:
Hatano Etsuro
Hatano Etsuro
中科院分区:
医学4区
文献类型:
--
作者:
Hirata Masaaki;Yagi Shintaro;Ito Takashi;Masano Yuki;Miyachi Yosuke;Yao Siyuan;Sonoda Mari;Masuda Satohiro;Haga Hironori;Hatano Etsuro

文献摘要

参考文献

相似文献

背景/目的本实验研究的目的是探讨极早期导入对大鼠的影响目的探讨部分肝移植术后(3 h内)应用依维莫司(EVR)+还原型他克莫司(TAC)对肝再生、排斥反应和存活率的影响。(实验1),同种异体30%部分LT(实验2)和整个LT结果在EVR +减少的TAC治疗中部分LT后,肝移植物重量恢复与标准剂量TAC单药治疗相比,在第3天(59.3%对72.9%;p<0.001)和第14天(88.1%对95.5%;p= 0.01),使用标准TAC。存活率为75%,没有标准TAC观察到的100%高,因为无法预防感染和排斥反应。相比之下,整个LT后的存活率为100%,因为既没有感染也没有排斥反应occurrency.ConclusionsThe非常早期的EVR +减少-TAC后,部分LT延迟肝再生,并使其难以管理所需的剂量,以抑制感染和排斥反应。另一方面,EVR +减少的TAC可以在整个LT后非常早地安全引入。
Background/PurposeThis experimental study in rats aimed to investigate the impact of very early introduction (within 3 h) of everolimus (EVR) + reduced‐tacrolimus (TAC) after partial liver transplantation (LT) on liver regeneration, rejection, and survival.MethodsBased on appropriate dose of EVR + reduced‐TAC in 70% hepatectomy (Experiment 1), allogeneic 30% partial LT (Experiment 2) and whole LT (Experiment 3) were performed.ResultsAfter partial LT in EVR + reduced‐TAC therapy, restoration of liver graft weight (to that of the whole liver) was delayed compared with standard dose TAC monotherapy (standard‐TAC) on day 3 (59.3% vs. 72.9%;p< .001) and 14 (88.1% vs. 95.5%;p= .01). Survival was 75%, which was not as high as the value of 100% observed for standard‐TAC, because neither infection nor rejection could be prevented. By contrast, survival after whole LT was 100% as neither infection nor rejection occurred.ConclusionsThe very early introduction of EVR + reduced‐TAC after partial LT delayed liver regeneration, and made it difficult to manage the dose required to suppress both infection and rejection. On the other hand, EVR + reduced‐TAC could be introduced safely very early after whole LT.
一种改良的血管“套筒”吻合术,用于大鼠原位肝移植的再动脉化。
DOI: --
发表时间: 1992
期刊: Transplantation
影响因子: 6.2
作者:
T. Liu;C. Freise;L. Ferrell;N. Ascher;J. Roberts
通讯作者: J. Roberts
DOI: 10.1002/lt.25879
发表时间: 2020-10-12
影响因子: 4.6
作者:
Saliba, Faouzi;Dharancy, Sebastien;Dumortier, Jerome
通讯作者: Dumortier, Jerome
DOI: 10.1111/j.1600-6143.2012.04212.x
发表时间: 2012-11
期刊: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子: --
作者:
De Simone P;Nevens F;De Carlis L;Metselaar HJ;Beckebaum S;Saliba F;Jonas S;Sudan D;Fung J;Fischer L;Duvoux C;Chavin KD;Koneru B;Huang MA;Chapman WC;Foltys D;Witte S;Jiang H;Hexham JM;Junge G;H2304 Study Group
通讯作者: H2304 Study Group
雷帕霉素对肝脏、肾脏和肠道再生的抑制作用
DOI: --
发表时间: 1992
期刊: Transplantation
影响因子: 6.2
作者:
K. A. Porter;S. Schreiber
通讯作者: S. Schreiber
DOI: 10.1111/j.1600-6143.2010.03128.x
发表时间: 2010-10-01
影响因子: 8.8
作者:
Masetti, M.;Montalti, R.;Gerunda, G. E.
通讯作者: Gerunda, G. E.